The DOI matches its Crossref record; 226 of the 231 references it cites were found in a registry or an index.
Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis
Open accessAbstract
Atopic dermatitis (AD) is an eczematous, pruritic skin disorder with extensive barrier dysfunction and elevated interleukin (IL)-4 and IL-13 signatures. The barrier dysfunction correlates with the downregulation of barrier-related molecules such as filaggrin (FLG), loricrin (LOR), and involucrin (IVL). IL-4 and IL-13 potently inhibit the expression of these molecules by activating signal transducer and activator of transcription (STAT)6 and STAT3. In addition to IL-4 and IL-13, IL-22 and IL-17A are probably involved in the barrier dysfunction by inhibiting the expression of these barrier-related molecules. In contrast, natural or medicinal ligands for aryl hydrocarbon receptor (AHR) are potent upregulators of FLG, LOR, and IVL expression. As IL-4, IL-13, IL-22, and IL-17A are all capable of inducing oxidative stress, antioxidative AHR agonists such as coal tar, glyteer, and tapinarof exert particular therapeutic efficacy for AD. These antioxidative AHR ligands are known to activate an antioxidative transcription factor, nuclear factor E2-related factor 2 (NRF2). This article focuses on the mechanisms by which FLG, LOR, and IVL expression is regulated by IL-4, IL-13, IL-22, and IL-17A. The author also summarizes how AHR and NRF2 dual activators exert their beneficial effects in the treatment of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Activation of NRF2 by AHR ligands such as coal tar abolished IL-4/IL-13–mediated inhibition of epidermal barrier proteins such as FLG and LOR (42, 56).”
From Particulate matter causes skin barrier dysfunction. (2021) · cites this paper as [42]
In the citing paper
“AhR ligands can also signal via Nuclear factor erythroid 2-related factor 2 (Nrf2)48–51, a pleiotropic transcription factor involved in redox homeostasis, metabolism, and immune modulation52.”
From Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy (2025) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhang, J., Sun, L., Li, W., Wang, Y., Li, X., & Liu, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108844 · Cited by 15
RetractedDiagnostic features of atopic dermatitis
Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086
Palmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1767 · Cited by 2,978
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., Silverberg, J. I., Deleuran, M., Kataoka, Y., Lacour, J.-P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1610020 · Cited by 2,110
The skin: an indispensable barrier
Proksch, E., Brandner, J. M., & Jensen, J. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00786.x · Cited by 2,054
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
IL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,406
Cytokine modulation of atopic dermatitis filaggrin skin expression
Howell, M. D., Kim, B. E., Gao, P., Grant, A. V., Boguniewicz, M., DeBenedetto, A., Schneider, L., Beck, L. A., Barnes, K. C., & Leung, D. Y. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.031 · Cited by 1,084
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris
Smith, F. J. D., Irvine, A. D., Terron-Kwiatkowski, A., Sandilands, A., Campbell, L., Zhao, Y., Liao, H., Evans, A. T., Goudie, D. R., Lewis‐Jones, S., et al. (2006) · Nature Genetics · doi:10.1038/ng1743 · Cited by 1,026
Flagged first, then by citations
5 of the 231 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 424
Canine Mesenchymal-Stem-Cell-Derived Extracellular Vesicles Attenuate Atopic Dermatitis
Cho, B. S., Kim, S., Kim, S., Rhee, B., Yoon, J., & Lee, J. W. (2023) · Animals · doi:10.3390/ani13132215 · Cited by 19
Chu, T. W., Ho, C.-C., Chiu, H.-P., Hsu, Y.-J., Hung, C.-T., Sung, C.-H., Chang, D.-C., Chang, H.-H., & Hung, C.-F. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114082 · Cited by 18
Tofacitinib for extraintestinal manifestations of inflammatory bowel disease: A literature review
Wang, Y., Wan, Z., Jin, R., Xu, T., Ouyang, Y., Wang, B., Ruan, G., & Bai, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108517 · Cited by 18
Kim, D. Y., Won, K., Hwang, D. I., Kim, N. Y., Kim, B., & Lee, H. M. (2022) · Molecules · doi:10.3390/molecules27051560 · Cited by 18
Wang, L., Yang, K., Jing, R., Zhao, W., Guo, K., Hu, Z., Liu, G., Xu, N., Zhao, J., Li, L., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1089537 · Cited by 18
Aryl hydrocarbon receptor role in chronic inflammatory skin diseases: a narrative review
Dec, M., & Arasiewicz, H. (2024) · Advances in Dermatology and Allergology · doi:10.5114/ada.2023.135617 · Cited by 22
Naumowicz, M., Modzelewski, S., Macko, A., Łuniewski, B., Baran, A. M., & Flisiak, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063482 · Cited by 18
Atopic Dermatitis: The Relationship Between Immune Mediators and Skin Lipid Barrier
You, H., & Liang, Y. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09057-y · Cited by 17
Oncostatin M suppresses IL31RA expression in dorsal root ganglia and interleukin-31-induced itching
Suehiro, M., Numata, T., Saito, R., Yanagida, N., Ishikawa, C., Uchida, K., Kawaguchi, T., Yanase, Y., Ishiuji, Y., McGrath, J. A., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1251031 · Cited by 17
Rusiñol, L., & Puig, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158437 · Cited by 18
Insights from Traditional Chinese Medicine for Restoring Skin Barrier Functions
Yang, J., Guo, J., Tang, P. L., Yan, S., Wang, X., Li, H., Xie, J., Deng, J., Hou, X., Du, Z., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17091176 · Cited by 17
Moving beyond biology: the critical role of social and structural determinants in atopic dermatitis
Polaskey, M. T., & Chovatiya, R. (2024) · International Journal of Dermatology · doi:10.1111/ijd.17491 · Cited by 17
Zhang, Y., Shu, M., Shan, S., Liu, H., Zhang, Y., Song, C., Xu, Q., Fan, Y., & Lu, C. (2025) · Advanced Science · doi:10.1002/advs.202409383 · Cited by 18
Haidar, L., Bănărescu, C. F., Uța, C., Zimbru, E.-L., Zimbru, R.-I., Tîrziu, A., Pătrașcu, R., Serb, A. F., Georgescu, M., Nistor, D., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13082014 · Cited by 16
Adipokines in atopic dermatitis: the link between obesity and atopic dermatitis
Zhang, S., Zhang, B., Liu, Y., & Li, L. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02009-z · Cited by 17
Jang, A.-Y., Choi, J., Rod–in, W., Choi, K. Y., Lee, D.-H., & Park, W. J. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2312.12002 · Cited by 15
Flori, E., Cavallo, A., Mosca, S., Kovacs, D., Cota, C., Zaccarini, M., Nardo, A. D., Bottillo, G., Maiellaro, M., Camera, E., et al. (2024) · Cells · doi:10.3390/cells13090760 · Cited by 15
Systematic characterization of the barrier function of diverse ex vivo models of damaged human skin
Barthe, M., Clerbaux, L., Thénot, J., Braud, V. M., & Osman‐Ponchet, H. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1481645 · Cited by 15
Atopic dermatitisReview of comorbidities and therapeutics
Appiah, M., Haft, M. A., Kleinman, E. P., Laborada, J., Lee, S., Loop, L., Geng, B., & Eichenfield, L. F. (2022) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2022.05.015 · Cited by 15
A review of short-Chain fatty acids in gut and skin: Possible implications in skin aging
Nambidi, S., Sennie, N. S., Kondaveeti, S. B., Banerjee, A., Pathak, S., & Duttaroy, A. K. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.107010 · Cited by 14
Inhibitory Effects of Donkey Hide Gelatin on DNCB-Induced Atopic Dermatitis in NC/Nga Mice
Lee, J. H., Dong, L., Noh, H. M., Park, S.-G., Kim, S., Jo, E. H., Lee, D., & Park, M. C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.896450 · Cited by 14
Sasakura, M., Urakami, H., Tachibana, K., Ikeda, K., Hasui, K., Matsuda, Y., Sunagawa, K., Ennishi, D., Tomida, S., & Morizane, S. (2024) · Allergology International · doi:10.1016/j.alit.2023.12.006 · Cited by 14
Zhang, K., Zhao, C., Liu, K., Feng, R., Zhao, Y. H., Zong, Y., & Du, R. (2024) · Nutrients · doi:10.3390/nu16111548 · Cited by 14
Kang, Y., Kim, H.-M., Lee, J., Baek, J.-S., Lee, M., & An, H. (2024) · Chinese Medicine · doi:10.1186/s13020-024-01042-5 · Cited by 15
Kim, H.-M., Kang, Y., Jin, B., Lee, H., Lee, D., Lee, M., & An, H. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154579 · Cited by 14
The epidermal lipid-microbiome loop and immunity: Important players in atopic dermatitis
Wu, J., Li, L., Zhang, T., Lu, J., Tai, Z., Zhu, Q., & Chen, Z. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.001 · Cited by 14
Potential Aspects of the Use of Cytokines in Atopic Dermatitis
Krupka‐Olek, M., Bożek, A., Aebisher, D., Bartusik‐Aebisher, D., Cieślar, G., & Kawczyk‐Krupka, A. (2024) · Biomedicines · doi:10.3390/biomedicines12040867 · Cited by 13
Role of interleukins in dermatology: Exploring the immune mechanisms in skin diseases
Prados‐Carmona, Á., Navarro‐Triviño, F. J., Ruíz‐Villaverde, R., & Corell, A. (2024) · JEADV Clinical Practice · doi:10.1002/jvc2.537 · Cited by 13
Fernando, I. P. S., Kirindage, K. G. I. S., Jayasinghe, A. M. K., Han, E. J., Lee, C., Heo, S., & Ahn, G. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.07.097 · Cited by 13
Atopic Dermatitis and Water: Is There an Optimum Water Intake Level for Improving Atopic Skin?
Douladiris, N., Vakirlis, E., & Vassilopoulou, Ε. (2023) · Children · doi:10.3390/children10020273 · Cited by 13
Lee, D., Kim, Y., Jo, H., Go, C., Jeong, Y., Jang, Y., Kang, D., Park, K., Kim, Y.-S., & Kang, J. S. (2021) · Antioxidants · doi:10.3390/antiox10060945 · Cited by 13
Characterization of a New Full-Thickness In Vitro Skin Model
Plaza, C., Meyrignac, C., Botto, J.-M., & Capallere, C. (2021) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2021.0035 · Cited by 13
Opioidergic Signaling—A Neglected, Yet Potentially Important Player in Atopic Dermatitis
Ádám, D., Arany, J., Tóth, K. F., Tóth, B. I., Szöllősi, A. G., & Oláh, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084140 · Cited by 13
Che-Wen, Y., Lin, F.-L., Chen, K.-H., Chen, J., Cheng, Y., & Guo, J. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118508 · Cited by 12
Serrano-Serra, J.-P., Montero‐Vílchez, T., Buendía‐Eisman, A., & Arias‐Santiago, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040888 · Cited by 12
Kim, M.-J., Hwang, B. S., Hwang, Y., Jeong, Y. T., Jeong, D. W., & Oh, Y. T. (2023) · Molecules · doi:10.3390/molecules28145463 · Cited by 12
Eichenfield, L. F., Silverberg, J. I., Hebert, A. A., & Boguniewicz, M. (2024) · Journal of Dermatological Treatment · doi:10.1080/09546634.2023.2300354 · Cited by 13
Chen, H.-W., Liu, F., Kuo, H., Tang, S.-H., Niu, G., Zhang, M. M., Tsou, L. K., Sung, P., & Wen, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116279 · Cited by 12
Bajsert, J., Glas, V. D., Faway, É., de Rouvroit, C. L., Pérez‐Aso, M., Cook, P. W., & Poumay, Y. (2024) · JID Innovations · doi:10.1016/j.xjidi.2024.100298 · Cited by 12
Dai, X., Mizukami, Y., Watanabe, K., Tsuda, T., Shidahara, M., Yoshida, S., Yatsuzuka, K., Shiraishi, K., Mori, H., Murakami, M., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.08.038 · Cited by 12
Enhancing Transcutaneous Drug Delivery: Advanced Perspectives on Skin Models
Ribeiro, A. R., Pereira‐Leite, C., Rosado, C., Aruci, E., Colley, H. E., Krohn, I. K., Baldea, I., Pantelić, I., Fluhr, J. W., Simões, S., et al. (2024) · JID Innovations · doi:10.1016/j.xjidi.2024.100340 · Cited by 12
No, H., Nam, S. H., Seo, H. W., Seo, J., Park, S.-H., Kim, S.-B., Jung, J., Park, J., Choi, J., Lee, J., et al. (2021) · Animal Cells and Systems · doi:10.1080/19768354.2021.1974938 · Cited by 12
Gil, T., Jin, B., & An, H. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.02.003 · Cited by 12
Neo, J. R. E., Teo, Z. N., Yeo, J. S. E., Ng, C. K. S., Teo, C. W. L., Ung, Y. W., & Yap, W. N. (2022) · Atmospheric Pollution Research · doi:10.1016/j.apr.2022.101564 · Cited by 13
Zhou, B., Liang, S., Shang, S., & Li, L. (2022) · Immunological Medicine · doi:10.1080/25785826.2022.2132683 · Cited by 12
CYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope Proteins
Niehues, H., Rikken, G., Kersten, F. F. J., Eeftens, J. M., van Vlijmen‐Willems, I. M. J. J., Rodijk‐Olthuis, D., Jansen, P. A. M., Hendriks, W. J. A. J., Ederveen, T. H. A., Schalkwijk, J., et al. (2023) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.01.022 · Cited by 12
Lee, Y., Lee, S., Park, S., Kang, S., Lee, J., Lee, D., Choi, W.-J., & Lee, W. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115677 · Cited by 12
Prignano, F., & Donetti, E. (2022) · Dermatology · doi:10.1159/000524119 · Cited by 12
Campbell, A.-C., Baik, J. E., Sarker, A., Brown, S., Park, H. J., Kuonqui, K. G., Shin, J., Pollack, B. L., Roberts, A., Ashokan, G., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.05.017 · Cited by 12
Differences in Behavior between Normal and Atopic Keratinocytes in Culture: Pilot Studies
Marsella, R., Ahrens, K. P., & Wilkes, R. (2022) · Veterinary Sciences · doi:10.3390/vetsci9070329 · Cited by 11
Elevation of IgE in patients with psoriasis: Is it a paradoxical phenomenon?
Shi, L., Liu, C., Xiong, H., & Shi, D. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1007892 · Cited by 11
Aryl Hydrocarbon Receptor as a Therapeutical Target of Environmentally Induced Skin Conditions
Freitas, C. A., da Silva, M. S., Santos, B. A. M. C., & Rodrigues, C. R. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.122.000627 · Cited by 11
Esophageal Mucosal Permeability as a Surrogate Measure of Cure in Eosinophilic Esophagitis
Chen, J., Oshima, T., Huang, X., Tomita, T., Fukui, H., & Miwa, H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144246 · Cited by 11
Andrzejczak, K., Sternak, A., Witkowski, W., & Ponikowska, M. (2025) · Cells · doi:10.3390/cells14181442 · Cited by 10
Ibáñez‐Cortés, M., Martín‐Piedra, M. Á., Blanco‐Elices, C., García‐García, Ó. D., España-López, A. J., Fernández‐Valadés, R., Sánchez‐Quevedo, M. D. C., Alaminos, M., Chato‐Astrain, J., & Garzón, I. J. (2023) · Microscopy Research and Technique · doi:10.1002/jemt.24398 · Cited by 10
Fusco, A., Perfetto, B., Savio, V., Chiaromonte, A., Torelli, G., Donnarumma, G., & Baroni, A. (2023) · Journal of Fungi · doi:10.3390/jof9121153 · Cited by 10
Propolis suppresses atopic dermatitis through targeting the MKK4 pathway
Cho, Y.-R., Han, E. J., Heo, E., Jayasinghe, A. M. K., Won, J., Lee, S., Kim, T., Kim, S., Lim, S., Woo, S. O., et al. (2024) · BioFactors · doi:10.1002/biof.2119 · Cited by 10
Environmental factors shaping atopic dermatitis: Lessons from longitudinal cohort studies
Lee, E., Yang, S., Suh, D. I., Kim, H., Lee, S., Kwon, S., & Hong, S. (2025) · Pediatric Allergy and Immunology · doi:10.1111/pai.70130 · Cited by 10
Andrzejczak, K., Kucharczyk, E., Sternak, A., Busłowicz, T., & Ponikowska, M. (2026) · Cells · doi:10.3390/cells15070594 · Cited by 11
Interleukin-22 and keratinocytes; pathogenic implications in skin inflammation
Furue, M., & Furue, M. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00005 · Cited by 10
Self-citationWater Extract of Rubus coreanus Prevents Inflammatory Skin Diseases In Vitro Models
Pyeon, S., Kim, O., Yoon, H., Kim, S., Choi, K., Lee, Y., Lee, J., Park, J., & Jun, W. (2021) · Plants · doi:10.3390/plants10061230 · Cited by 10
Jamerson, T. A., Li, Q., Sreeskandarajan, S., Budunova, I. V., He, Z., Kang, J., Gudjonsson, J. E., Patrick, M. T., & Tsoi, L. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.845655 · Cited by 10
Galectin-9 contributes to the pathogenesis of atopic dermatitis via T cell immunoglobulin mucin-3
Su, W., Zhang, J., Yang, S., Tang, M., Shen, Y., Liu, C., Ji, J., Maurer, M., & Jiao, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.952338 · Cited by 10
Wu, Q., Xie, T., Lu, J., Jia, T., & Kaku, K. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2023.9439 · Cited by 10
An overview of new and emerging antibody therapies for moderate-severe atopic dermatitis in adults
Picone, V., Vallone, Y., Patruno, C., & Napolitano, M. A. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2292615 · Cited by 10
Li, H., Liang, J., Li, P., Li, X., Liu, Q., Yang, S.-X., Zhang, C., Liu, S., He, Y., & Tan, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1413513 · Cited by 10
Nishikawa, Y., Fukaya, T., Fukui, T., Uto, T., Takagi, H., Nasu, J., Miyanaga, N., Riethmacher, D., Choijookhuu, N., Hishikawa, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.712676 · Cited by 10
Samulevich, M. L., Shamilov, R., & Aneskievich, B. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214323 · Cited by 9
Goleij, P., Amini, A., Tabari, M. A. K., Hadipour, M., Rezaee, A., Daglia, M., Aschner, M., Sanaye, P. M., Kumar, A. P., & Khan, H. Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114399 · Cited by 9
Kim, H. J., Park, M., Jang, S., Song, H., Lee, S. K., & Kim, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072994 · Cited by 9
Yang, F., Wang, H., Luo, D., Deng, J., Hu, Y., Liu, Z., & Liu, W. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17080956 · Cited by 9
Bagher, A. M. (2025) · Pharmaceuticals · doi:10.3390/ph18111605 · Cited by 9
Liu, Q., Li, M., Wang, N., Chun, H., Jiang, X. L., & Li, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911371 · Cited by 9
Donetti, E., Riva, F., Indino, S., Lombardo, G., Preis, F. B., Rosi, E., & Prignano, F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051941 · Cited by 9
The effects of HPV oncoproteins on host communication networks: Therapeutic connotations
Skelin, J., Luk, H. Y., Butorac, D., Boon, S. S., & Tomaić, V. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29315 · Cited by 9
Kim, S., Kang, B.-G., Sa, S., Park, S. Y., Ryu, K., Lee, J.-Y., Park, B.-R., Kwon, M., Kim, Y.-H., Kim, J., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1383779 · Cited by 9
Potential Role of IL-37 in Atopic Dermatitis
Mesjasz, A., Trzeciak, M., Gleń, J., & Jaskulak, M. (2023) · Cells · doi:10.3390/cells12232766 · Cited by 10
Wang, X., Zhang, Y., Jin, T., Botchway, B. O. A., Fan, R., Wang, L., & Liu, X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.830346 · Cited by 10
Kim, M., Yuk, H. J., Min, Y., Kim, D.-S., & Sung, Y.-Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115903 · Cited by 8
Chou, W.-L., Yang, S.-C., Alshetaili, A., Wei, S.-H., Yang, S.-H., & Fang, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113486 · Cited by 8
Liana, D., Chatwichien, J., & Phanumartwiwath, A. (2024) · ACS Nanoscience Au · doi:10.1021/acsnanoscienceau.4c00053 · Cited by 8
Xu, J., Sun, X., Qin, F., Wang, X., Chen, Q., & Yan, R. (2023) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2023.2204949 · Cited by 8
Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
Migayron, L., Bordes, S., Closs, B., Sénéschal, J., & Boniface, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1405215 · Cited by 8
Evaluation of the Therapeutic Effect of Sacha Inchi Oil in Atopic Dermatitis Mice
Zhang, Y., Zhao, W., Liao, J., Zhang, Y., Wang, L., Li, P., & Du, B. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112552 · Cited by 8
Mareso, C., Albion, E., Cozza, W., Tanzi, B., Cecchin, S., Gisondi, P., Michelini, S., Bellinato, F., Michelini, S., Michelini, S., et al. (2023) · Molecular Biology Reports · doi:10.1007/s11033-022-08170-x · Cited by 8
Lee, J. Y., Lee, J., Lim, H. J., Kim, E., Kim, D., & Choi, J. K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1215861 · Cited by 8
Nedorost, S. T., Zhang, G., Fekedulegn, D. B., Fluharty, K. L., Wang, W., Frye, B. L., Baron, E., Zug, K. A., & Yücesoy, B. (2025) · JID Innovations · doi:10.1016/j.xjidi.2025.100382 · Cited by 7
A translational approach to improve therapeutics in atopic dermatitis and beyond
Liu, D., Patel, D., Lau, M., Largen, J., Hu, B., He, H., & Guttman‐Yassky, E. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf049 · Cited by 7
Atopic dermatitis-related anti-inflammatory in vitro effects of a plant extract mixture
Heinemann, N., Rademacher, F., Vollert, H., Gläser, R., & Harder, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-09053-4 · Cited by 7
Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
Cheng, J., Jiang, Y., Chen, Q., & Xiao, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1641918 · Cited by 7
Na, Y., Kim, Y., Lee, J. H., & Sung, G. Y. (2025) · BioChip Journal · doi:10.1007/s13206-025-00237-8 · Cited by 7
Kim, K., Jang, H., Kim, E., Kim, H., & Sung, G. Y. (2025) · Lab on a Chip · doi:10.1039/d5lc00606f · Cited by 7
Yes-associated protein regulates autophagy to restore skin barrier function in atopic dermatitis
Jia, J., Ma, X., Wang, T. A., Ye, S., Yan, F., Liu, J., Li, H., Chen, D., & Mo, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1681148 · Cited by 7
Tu, Y., Gu, H., Li, N., Sun, D., Yang, Z., & He, L. (2024) · Inflammation · doi:10.1007/s10753-024-02174-4 · Cited by 7
Vitamin D and Atopic Dermatitis—A Mere Correlation or a Real Supportive Treatment Option?
Przechowski, K., Krawczyk, M. N., Krasowski, R., Pawliczak, R., & Kleniewska, P. (2025) · Nutrients · doi:10.3390/nu17162582 · Cited by 8
Li, S., Wang, L., Zhang, Y., Ma, L., Zhang, J., Zu, J., & Wu, X. (2021) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2104.04028 · Cited by 7
The Prebiotic Effect of Triple Biotic Technology on Skin Health
Li, M., Fan, A., Mao, J., Soliman, N., Shahani, K., Morgan, A. M., & Boyd, T. (2021) · Journal of Cosmetics Dermatological Sciences and Applications · doi:10.4236/jcdsa.2021.114025 · Cited by 7
Kim, J., Jung, E., Yang, W., Kim, C.-K., Durnaoglu, S., Oh, I., Kim, C., Sinskey, A. J., Mihm, M. C., & Lee, J. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612979 · Cited by 7
Zang, S., Chen, J., Chevalier, C., Zhang, J., Li, S., Wang, H., Li, J., Chen, Y., Xu, H., Sheng, L., et al. (2024) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.16489 · Cited by 6
Heikkilä, A., Sliz, E., Huilaja, L., FinnGen, Reis, K., Priit, P., Elnahas, A. G., Reigo, A., Esko, T., Laisk, T., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.03.043 · Cited by 7
Metadata
- Authors
- Furue, M.
- Affiliations
- Kyushu University (JP)
- Corresponding author
- Furue, Masutaka
- ORCID
- Furue, Masutaka
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-07-29
- Volume
- 21
- Issue
- 15
- Pages
- 5382
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7432778
- OpenAlex
- W3046068546
- Cited by
- 419
- References
- 231
- Citations by year
- 2026: 83 · 2025: 82 · 2024: 81 · 2023: 74 · 2022: 64 · 2021: 32 · 2020: 2
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Health, Labour and Welfare (H30-Shokuhin-Shitei-005)
- Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (C, FAG0K08692)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Keywords
- atopic dermatitis, filaggrin, loricrin, involucrin, skin barrier dysfunction, IL-4, IL-13, IL-17A, IL-22, aryl hydrocarbon receptor, Nrf2, STAT6, STAT3, oxidative stress, coal tar, tapinarof, AhR agonists
- MeSH terms
- Filaggrin Proteins, Interleukin-22, Antioxidants, Coal Tar, Dermatitis, Atopic, Gene Expression Regulation, Humans, Interleukins, Membrane Proteins, S100 Proteins, Protein Precursors, Resorcinols, Skin, Stilbenes, Tars, Signal Transduction, Interleukin-4, Receptors, Aryl Hydrocarbon, Oxidative Stress, Interleukin-13, Interleukin-17, STAT3 Transcription Factor, STAT6 Transcription Factor, NF-E2-Related Factor 2, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review